Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women

Maturitas

Volumn 79, Issue 1, 2014, Pages 70-76

  Kabat, Geoffrey C ^a   Kamensky, Victor ^a   Heo, Moonseong ^a   Bea, Jennifer W ^b   Hou, Lifang ^c   Lane, Dorothy S ^d   Liu, Simin ^e   Qi, Lihong ^f   Simon, Michael S ^g   Wactawski Wende, Jean ^h   Rohan, Thomas E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e BROWN UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g KARMANOS CANCER INSTITUTE   (United States)

^h UNIVERSITY AT BUFFALO   (United States)

Author keywords

Androgens; Breast cancer; Conjugated esterified estrogen plus methyltestosterone supplementation; Postmenopausal women

Indexed keywords

CONJUGATED ESTROGEN PLUS METHYLTESTOSTERONE; CONJUGATED ESTROGEN; METHYLTESTOSTERONE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANCER RISK; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PHYSICAL ACTIVITY; POSTMENOPAUSE; SMOKING; TREATMENT DURATION; AGE; BODY MASS; BREAST NEOPLASMS; CAUCASIAN; COMPARATIVE STUDY; DRINKING BEHAVIOR; EDUCATIONAL STATUS; ESTROGEN THERAPY; HEALTH SURVEY; INCOME; MAMMOGRAPHY; MATERNAL AGE; MIDDLE AGED; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; AGED; ALCOHOL DRINKING; BODY MASS INDEX; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; EDUCATIONAL STATUS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); ESTROGENS, ESTERIFIED (USP); EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCOME; MAMMOGRAPHY; MATERNAL AGE; METHYLTESTOSTERONE; MIDDLE AGED; POPULATION SURVEILLANCE; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84928060012     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.06.006     Document Type: Article

References (31)

1. M.C. Snabes, and S.M. Simes Approved hormonal treatments for HSDD: an unmet medical need (Commentary) J Sex Med 6 2009 1846 1849
2. E.H. Phillips, S. Ryan, R. Ferrari, and C. Green Estratest and Estratest HS (esterified estrogens and methyltestosterone) therapy: a summary of safety surveillance data January 1989 to August 2002 Clin Ther 25 2003 3027 3043
3. K. Margo, and R. Winn Testosterone treatments: why, when, and how? Am Fam Physician 73 2006 1591 1598
4. G.D. Cameron Braunstein Androgen replacement therapy in women Fertil Steril 82 2004 273 289
5. S. Basaria, and A. Dobs Controversies regarding transdermal androgen therapy in postmenopausal women J Clin Endocrinol Metab 91 2006 4743 4752
6. R.B. Ness, J.D. Albano, A. McTiernan, and J.A. Cauley Influence of estrogen plus testosterone supplementation on breast cancer Arch Intern Med 169 2009 41 46
7. R.M. Tamimi, S.E. Hankinson, W.Y. Chen, B. Rosner, and G. Colditz Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women Arch Intern Med 166 2006 1483 1489
8. C. Dimitrakakis, R.A. Jones, A. Liu, and C.A. Bondy Breast cancer incidence in postmenopausal women using testosterone in addition to the usual hormone therapy Menopause 11 2004 531 535
9. C. Dimitrakakis Androgens and breast cancer in men and women Endocrinol Metab Clin North Am 40 2011 533 547
10. J.A. Simon Safety of estrogen/androgen regimens J Reprod Med 46 2001 281 290
11. W. Somboonporn, and S.R. Davis Testosterone effects on the breast: implications for testosterone therapy for women Endocr Rev 25 2004 374 388
12. C.L. Shufelt, and G.D. Braunstein Testosterone and the breast Menopause Int 14 2008 117 122
13. M. Ewertz Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark Int J Cancer 42 1988 832 838
14. S.R. Davis, M. Moreau, and R. Kroll et al. Testosterone for low libido in postmenopausal women not taking estrogen New Engl J Med 359 2008 2005 2017
15. R.A. Lobo, R.C. Rosen, H.-M. Yang, B. Block, and R.G. van der Hoop Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire Fertil Steril 79 2003 1341 1352
16. C. Dimitrakakis, J. Zhou, and J. Wang et al. A physiologic role for testosterone in limiting estrogenic stimulation of the breast Menopause 10 2003 292 298
17. J. Zhou, S. Ng, O. Adesanya-Famuiya, K. Anderson, and C.A. Bondy Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression FASEB J 14 2000 1725 1730
18. The Women's Health Initiative Study Group Design of the Women's Health Initiative clinical trial and observational study Control Clin Trials 19 1998 61 109
19. R.D. Langer, E. White, and C.E. Lewis et al. The Women's Health Initiative observational study: baseline characteristics of participants and reliability of baseline measures Ann Epidemiol 13 9 Suppl. 2003 S107 S121
20. J.D. Curb, A. McTiernan, and S.R. Heckbert et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative Ann Epidemiol 13 9 Suppl. 2003 S122 S128
21. M.H. Gail Evaluating serial cancer marker studies in patients at risk of recurrent disease Biometrics 37 1981 67 78
22. L.A. Brinton, R. Hoover, and J.F. Fraumeni Jr. Menopausal oestrogens and breast cancer risk: an expanded case-control study Br J Cancer 54 1986 825 832
23. G.A. Colditz, S.E. Hankinson, and D.J. Hunter et al. The use of estrogens and progestin and the risk of breast cancer in postmenopausal women N Engl J Med 332 1995 1589 1593
24. J. Bitzer, P. Kenemans, and A.O. Mueck Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy Maturitas 59 2008 209 218
25. W. Somboonporn, and S.R. Davis Postmenopausal testosterone therapy and breast cancer risk Maturitas 49 2004 267 275
26. M. Hofling, A.L. Hirschberg, L. Skoog, E. Tani, T. Hägerström, and B. von Schoultz Testosterone inhibits estrogen/progestogen-induced cell proliferation in postmenopausal women Menopause 14 2007 183 190
27. M. Hofling, L. Löfgren, B. von Schoultz, K. Carlström, and G. Söderqvist Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women Gynecol Endocrinol 24 2008 405 410
28. A.A. Peters, G. Buchanan, and C. Ricciardelli et al. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic of breast cancer Cancer Res 69 2009 6131 6140
29. T.E. Hickey, J.L. Robinson, J.S. Carroll, and W.D. Tilley Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol 26 2012 1252 1267
30. A.S. Doane, M. Danso, and P. Lal et al. An estrogen receptor-negative breast cancer subset characterized by hormonally regulated transcriptional program and response to androgen Oncogene 25 2006 3994 4008
31. G.C. Kabat, M.Y. Kim, and J. Luo et al. Menstrual and reproductive factors and endogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women Eur J Cancer Prev 22 2013 409 416